Interspecies transfer of blaIMP-4 in a patient with prolonged colonization by IMP-4-producing Enterobacteriaceae

Hanna E Sidjabat1, Claire Heney2, Narelle M George2

  • 1The University of Queensland, UQ Centre for Clinical Research, Herston, Queensland, Australia h.sidjabat@uq.edu.au.

Insights

This study details prolonged colonization of a patient with IMP-4 producing bacteria, including Enterobacter cloacae and Escherichia coli, for seven months. It highlights the first documented instance of in vivo interspecies transfer of the blaIMP-4 gene.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Molecular Biology

Background:

  • Antimicrobial resistance is a growing global health threat.
  • Carbapenemase-producing Enterobacteriaceae (CPE) are of particular concern due to limited treatment options.
  • Understanding the mechanisms and dynamics of resistance gene spread is crucial for effective control strategies.

Observation:

  • A patient exhibited prolonged colonization (7 months) with both Enterobacter cloacae and Escherichia coli strains carrying the IMP-4 carbapenemase gene.
  • Both bacterial species harbored identical genetic elements, including the blaIMP-4 gene, blaTEM-1, qnrB2, aacA4, HI2 plasmids, and ISCR1.
  • The temporal isolation patterns suggest the persistence and potential transfer of these genetic elements between species within the patient.

Findings:

  • This study reports the first documented case of prolonged in vivo interspecies transfer of the blaIMP-4 gene.
  • The genetic relatedness of the isolates indicates a shared source or successful horizontal gene transfer event.
  • The co-occurrence of multiple resistance genes (blaIMP-4, blaTEM-1, qnrB2, aacA4) on transferable plasmids (HI2) amplifies the resistance phenotype.

Implications:

  • Prolonged colonization with multidrug-resistant organisms poses a significant risk for healthcare-associated infections.
  • The findings underscore the potential for rapid dissemination of carbapenem resistance genes between different bacterial species in clinical settings.
  • This highlights the need for enhanced surveillance and infection control measures to prevent the spread of IMP-4 and other carbapenemases.